Literature DB >> 17618400

Clarithromycin induced torsade de pointes.

C Hensey1, D Keane.   

Abstract

BACKGROUND: Clarithromycin is a commonly used macrolide antibiotic. It is known to cause QT prolongation. Medication induced QT prolongation is a major risk factor for the development of torsade de pointes.
METHODS: A 79-year-old lady presented with frequent episodes of torsade de pointes following commencement of clarithromycin. This was noted to be in association with a prolongation of the QT interval.
CONCLUSION: Knowledge of medications which prolong the QT interval is important to minimize the risk of ventricular arrhythmias, which may lead to sudden death. This is essential in patients with a congenitally long QT interval.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17618400     DOI: 10.1007/s11845-007-0057-3

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  5 in total

Review 1.  Torsades de pointes induced by erythromycin.

Authors:  B Gitler; L S Berger; S D Buffa
Journal:  Chest       Date:  1994-02       Impact factor: 9.410

2.  Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.

Authors:  R R Makkar; B S Fromm; R T Steinman; M D Meissner; M H Lehmann
Journal:  JAMA       Date:  1993-12-01       Impact factor: 56.272

3.  Bradycardia-induced abnormal QT prolongation in patients with complete atrioventricular block with torsades de pointes.

Authors:  T Kurita; T Ohe; N Marui; N Aihara; H Takaki; S Kamakura; M Matsuhisa; K Shimomura
Journal:  Am J Cardiol       Date:  1992-03-01       Impact factor: 2.778

4.  Low penetrance in the long-QT syndrome: clinical impact.

Authors:  S G Priori; C Napolitano; P J Schwartz
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

Review 5.  Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia.

Authors:  S H Hohnloser; T Klingenheben; B N Singh
Journal:  Ann Intern Med       Date:  1994-10-01       Impact factor: 25.391

  5 in total
  4 in total

1.  Macrolide antibiotics and the risk of ventricular arrhythmia in older adults.

Authors:  Mai H Trac; Eric McArthur; Racquel Jandoc; Stephanie N Dixon; Danielle M Nash; Daniel G Hackam; Amit X Garg
Journal:  CMAJ       Date:  2016-02-22       Impact factor: 8.262

Review 2.  Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period.

Authors:  Emanuel Raschi; Elisabetta Poluzzi; Chiara Zuliani; Arno Muller; Herman Goossens; Fabrizio De Ponti
Journal:  Br J Clin Pharmacol       Date:  2008-11-17       Impact factor: 4.335

3.  Clarithromycin, QTc interval prolongation and torsades de pointes: the need to study case reports.

Authors:  W Victor R Vieweg; Jules C Hancox; Mehrul Hasnain; Jayanthi N Koneru; Michael Gysel; Adrian Baranchuk
Journal:  Ther Adv Infect Dis       Date:  2013-08

4.  Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study.

Authors:  Henrik Svanström; Björn Pasternak; Anders Hviid
Journal:  BMJ       Date:  2014-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.